Drug Trial Radar · NCT05245591
Radiation Cystitis Treated With Pentosan Polysulfate Sodium Trial
Last checked: Nov 19, 2026Latest source record: May 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
72
Planned (sponsor's estimate)
Start
Apr 29, 2022
Primary completion
Nov 1, 2024
Study completion Nov 1, 2029
Sponsor
- Lead sponsor
- National Taiwan University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- TCM Biotech International Corporation
- First posted
- Feb 18, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of pentosan polysulfate sodium versus placebo and in patients with radiation cystitis who have received radiation therapy in pelvic region.
Conditions
- Radiation Cystitis
Interventions
Pentosan Polysulfate Sodium 100 MG Oral CapsuleDrug
Pentosan Polysulfate Sodium 100 mg three times daily (tid) for 0-8 weeks Pentosan Polysulfate Sodium 100 mg twice daily (bid) for 9-16 weeks
PlaceboDrug
Placebo 100 mg three times daily (tid) for 0-8 weeks Placebo 100 mg twice daily (bid) for 9-16 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of complete remission in lower urinary tract symptoms and hematuriaTime frame: From date of randomization throughout the treatment period up to 5 years
- Time to complete remissionTime frame: From date of randomization to study completion up to 5 years
- Time to hematuria recurrenceTime frame: From date of randomization to study completion up to 5 years
- Assessment of quality of lifeTime frame: From date of randomization to study completion up to 5 years
- Assessment of symptomsTime frame: From date of randomization to study completion up to 5 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Taiwan University Hospital
Taipei, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.